Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Novartis launch NET cancer community app

Galaxies of Hope aims to provide support to cancer patients

Galaxies of HopeFollowing its release of a remote clinical trial app, Novartis has honed in on digital once again, this time launching an app designed to support the Neuroendocrine Tumour (NET) cancer community.

NET is a type of cancer that develops from cells that specifically produce and secrete a variety of hormones that regulate bodily functions.

There are several types of NET cancers that can occur throughout the body, but most are found in the gastrointestinal tract, pancreas and lungs.

Novartis, which said that raising awareness of NET cancer is important in improving understanding and management of this rare disease, has launched Galaxies of Hope as an aid to this.

The app engages users through visual storytelling, using the real voices of patients, caregivers and physicians.

Ameet Mallik, executive vice president and head of US oncology at Novartis, said: We believe that this app can have a real, positive impact in the NET cancer community and we hope the creation of this virtual patient journey experience for the NET cancer community will provide support to those living with this rare disease and those who manage and care for them.”

The app will be available for download in the US on the Google Play Store.

Article by
Gemma Jones

17th July 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics